Meldonium and Moral Fault: Five Lessons Learned from the Sharapova ITF Tribunal Decision
In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its use by athletes with the intention of enhancing performance” (Explanatory Notice to the 2016 List). Few observers could have predicted [...]